Russian Association of Endocrinologists about the introduction of Diabeton MR (60 mg tablets)
Хорошо известный препарат Диабетон МВ 30 мг успешно применяется в России и мире для лечения больных сахарным диабетом 2 типа (СД2) с 2000 года. Доказанная эффективность и безопасность Диабетона МВ 30 мг послужила основанием для его широкого применения в клинической практике, включения в Российские и...
Saved in:
Main Author: | Editorial team Diabetes Mellitus |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/cc410f8904b94babb9f3a82eba8cb1a3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopharmaceuticals. Official position of Russian Association of Endocrinologists
by: Editorial team Diabetes Mellitus
Published: (2013) -
Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
by: Olga Konstantinovna Vikulova
Published: (2012) -
Russian Association of Endocrinologists reports commencement of Trajenta clinical use
by: Editorial team Diabetes Mellitus
Published: (2012) -
Influence of intensive glycemic control on development and progression of diabetic nephropathy in patients with type 2 diabetes mellitus (based on results from ADVANCE study)
by: Inna Igorevna Klefortova
Published: (2012) -
Anniversary of Russian association of endocrinologists
by: Natalya Pavlovna Makolina
Published: (2015)